Clinical Trials
4 trialsNCT03058289 2025-02-27
IT-01
Intensity Therapeutics, Inc.
Phase 1/2 Completed
NCT03841110 2023-05-01
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Fate Therapeutics
Phase 1 Completed
NCT03458117 2022-03-18
20139157 T-VEC
University of Zurich
Phase 1 Completed
NCT00581815 2015-12-28
Spectroscopy With Surface Coils and Decoupling
Memorial Sloan Kettering Cancer Center
Phase 1 Completed